FoGia
Involved In Discussions
Hi there,
I've pondering the MEDDEV 2.7/1 rev 4 on clinical evaluation for quite some time now but the concepts of clinical performance & clinical safety claims still elude me.
The guideline points to the definitions of clinical performance (from ISO 14155) and clinical safety (from MEDDEV 2.7/2) without providing clear examples as to when a claim can be considered a performance or safety claim. It's especially confusing since the two concepts are used together throughout the guideline. I can't find on the web, on the site of IMDRF or other references to these concepts. What am I missing?
An example: are biocompatibility/sterilizability/compatibility performance or safety claims? Following the definitions I'd say those are performance claims (the device performs as intended). They're however not part of the intended use and I'm tempted to classify them as clinical safety claims since they're not serving the primary performance intended by the manufacturer.
But from the defintion standpoint, clinical safety claims aren't "freedom from unacceptable risks" just another way to describe the indications for use?
Could you help me articulate these notions?
Thanks
I've pondering the MEDDEV 2.7/1 rev 4 on clinical evaluation for quite some time now but the concepts of clinical performance & clinical safety claims still elude me.
The guideline points to the definitions of clinical performance (from ISO 14155) and clinical safety (from MEDDEV 2.7/2) without providing clear examples as to when a claim can be considered a performance or safety claim. It's especially confusing since the two concepts are used together throughout the guideline. I can't find on the web, on the site of IMDRF or other references to these concepts. What am I missing?
An example: are biocompatibility/sterilizability/compatibility performance or safety claims? Following the definitions I'd say those are performance claims (the device performs as intended). They're however not part of the intended use and I'm tempted to classify them as clinical safety claims since they're not serving the primary performance intended by the manufacturer.
But from the defintion standpoint, clinical safety claims aren't "freedom from unacceptable risks" just another way to describe the indications for use?
Could you help me articulate these notions?
Thanks